Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection

Vaccine

Volumn 15, Issue 11, 1997, Pages 1235-1238

  De Martino, Maurizio ^a   Podda, Audino ^b,c   Galli, Luisa ^d   Sinangil, Faruk ^b,c   Mannelli, Francesco ^d   Rossi, Maria Elisabetta ^d   Vierucci, Alberto ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b CHIRON VACCINES   (Italy)

^c University of Florence ^*  (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acellular pertussis vaccine; HIV 1 perinatal infection; Immunization; Pertussis

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; HEMAGGLUTININ; IMMUNOGLOBULIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; ZIDOVUDINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERINATAL INFECTION; PERTUSSIS; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LINEAR MODELS; MALE; PERTUSSIS VACCINE; PILOT PROJECTS;

EID: 0030752731     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00024-8     Document Type: Article

References (22)

1. Katz, S.L. Immunizations for HIV-infected children. In: Pediatric AIDS. The Challenge of HIV Infection in Infants, Children, and Adolescents, 2nd edn (Eds Pizzo P.A. and Wilfert, C.M.). Williams and Wilkins, Baltimore, 1995, pp. 859-867.
2. Italian Register for HIV Infection in Children Vaccination in children born to HIV-infected mothers. Riv. Ital. Ped. 1994, 20, 284-288.
3. de Martino, M., Tovo, P.A. and Galli, L. et al. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994, 343, 191-195.
4. Doebbeling, B.N., Fellmeier, M.L. and Herwaldt, L.A. Pertussis in an adult man infected with the human immunodeficiency virus. J. Infect. Dis. 1990, 161, 1296-1298.
5. Colebunders, R., Vael, C., Blot, K., Van Meerbeeck, J., Van den Ende, J. and Ievem, M. Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13, 313-315.
6. Binkin, N.J., Salmaso, S., Tozzi, A.E., Scudery, G. and Greco, D. Epidemiology of pertussis in a developed country with low vaccination coverage. The Italian experience. Pediatr. Infect. Dis. J. 1992, 11, 653-661.
7. Podda, A., Carapella De Luca, E. and Titone, L. et al. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children. J. Pediatr. 1993, 123, 81-84.
8. Centers for Disease Control and Prevention 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morbid. Mortal. Wkly Rep. 1994, 43, 1-13.
9. Podda, A., Nencioni, L. and De Magistris, M.T. et al. Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J. Exp. Med. 1990, 172, 861-868.
10. Manclark, C.R., Meade, B.D. and Burstyn, D.G. Serological response to Bordetella pertussis. In: Manual of Clinical Laboratory Immunology (Eds Rose, N.R., Friedman H. and Fahey, J.L.). American Society for Microbiology, Washington, 1986, pp. 388-394.
11. Pichichero, M.E., Green, J.L., Francus, A.B., Marsocci, S.M., Lynd, M. and Litteer, T. Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children. Pediatr. Infect. Dis. J. 1994, 13, 193-196.
12. Greco, D., Salmaso, S. and Mastrantonio, P. et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 1996, 334, 341-348.
13. Ryder, R.W., Oxtoby, M.J. and Mvula, M. et al. Safety and immunogenicity of bacille Calmette-Guérin, diphteria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J. Pediatr. 1993, 122, 697-702.
14. Edwards, K.M. and Decker, M.D. Acellular pertussis vaccines for infants. N. Engl. J. Med. 1996, 334, 391-392.
15. Kroon, F.P., van Dissel, J.T., de Jong, J.C. and van Furth, R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994, 8, 469-476.
16. Zuccotti, G.V., Riva, E. and Flumine, P. et al. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J. Pediatr. 1994, 125, 70-72.
17. Peters, V.B. and Sood, S.K. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J. Pediatr. 1994, 125, 74-77.
18. Rudy, B.J., Rutstein, R.M. and Pinto-Martin, J. Responses to measles immunization in children infected with human immunodeficiency virus. J. Pediatr. 1994, 125, 72-74.
19. De Magistris, M.T., Di Tommaso, A. and Domenghini, M. et al. Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. Immunology 1992, 89, 2990-2994.
20. Ahmed, F., Steinhoff, M.C., Rodriguez-Barradas, M.C., Hamilton, R.G., Musher, D.M. and Nelson, K.E. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J. Infect. Dis. 1996, 173, 83-90.
21. Arpadi, S.M., Back, S., O'Brien, J. and Janoff, E.N. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. J. Pediatr. 1994, 125, 77-79.
22. Stanley, S.K., Ostrowski, M.A. and Justement, J.S. et al. New Engl. J. Med. 1996, 334, 1222-1230.